메뉴 건너뛰기




Volumn 14, Issue , 2016, Pages

Platelets and platelet adhesion molecules: Novel mechanisms of thrombosis and anti-thrombotic therapies

Author keywords

Anfibatide; GPIb ; GPVI; Hemostasis; Integrins; P selectin; Stroke; Thrombosis; IIb 3

Indexed keywords

ABCIXIMAB; ALPHAIIBBETA3 INTEGRIN; ALPHALBETA2 INTEGRIN; ANFIBATIDE; ANTITHROMBOCYTIC AGENT; CAPLACIZUMAB; CD40 LIGAND; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; EGAPTIVON PEGOL; EPTIFIBATIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IB IX V COMPLEX; GLYCOPROTEIN VI; INTEGRIN; PADGEM PROTEIN; PRASUGREL; THROMBOCYTE RECEPTOR; TICAGRELOR; TIROFIBAN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6; VITRONECTIN RECEPTOR; VORAPAXAR;

EID: 84990030062     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/s12959-016-0100-6     Document Type: Review
Times cited : (155)

References (154)
  • 1
    • 0036851876 scopus 로고    scopus 로고
    • Platelets in atherothrombosis
    • Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-34.
    • (2002) Nat Med , vol.8 , pp. 1227-1234
    • Ruggeri, Z.M.1
  • 2
    • 39749109478 scopus 로고    scopus 로고
    • Triggers, targets and treatments for thrombosis
    • Mackman N. Triggers, targets and treatments for thrombosis. Nature. 2008;451:914-8.
    • (2008) Nature , vol.451 , pp. 914-918
    • Mackman, N.1
  • 3
    • 84989895722 scopus 로고    scopus 로고
    • Platelets, immune-mediated thrombocytopenias, and fetal hemorrhage
    • Xu XR, Gallant RC, Ni H. Platelets, immune-mediated thrombocytopenias, and fetal hemorrhage. Thromb Res. 2016;141 Suppl 2:S76-9.
    • (2016) Thromb Res , vol.141 , pp. S76-S79
    • Xu, X.R.1    Gallant, R.C.2    Ni, H.3
  • 4
    • 0037410214 scopus 로고    scopus 로고
    • Platelets in hemostasis and thrombosis: role of integrins and their ligands
    • Ni H, Freedman J. Platelets in hemostasis and thrombosis: role of integrins and their ligands. Transfus Apher Sci. 2003;28:257-64.
    • (2003) Transfus Apher Sci , vol.28 , pp. 257-264
    • Ni, H.1    Freedman, J.2
  • 5
    • 33748753772 scopus 로고    scopus 로고
    • Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo
    • Yang H, Reheman A, Chen P, Zhu G, Hynes RO, Freedman J, et al. Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost. 2006;4:2230-7.
    • (2006) J Thromb Haemost , vol.4 , pp. 2230-2237
    • Yang, H.1    Reheman, A.2    Chen, P.3    Zhu, G.4    Hynes, R.O.5    Freedman, J.6
  • 6
    • 84957928395 scopus 로고    scopus 로고
    • Extracellular matrix proteins in the regulation of thrombus formation
    • Wang Y, Gallant RC, Ni H. Extracellular matrix proteins in the regulation of thrombus formation. Curr Opin Hematol. 2016;23:280-7.
    • (2016) Curr Opin Hematol , vol.23 , pp. 280-287
    • Wang, Y.1    Gallant, R.C.2    Ni, H.3
  • 7
    • 0024426540 scopus 로고
    • A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion
    • Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989;84:1440-5.
    • (1989) J Clin Invest , vol.84 , pp. 1440-1445
    • Moroi, M.1    Jung, S.M.2    Okuma, M.3    Shinmyozu, K.4
  • 9
    • 0026495238 scopus 로고
    • Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets
    • Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-51.
    • (1992) Nature , vol.359 , pp. 848-851
    • Palabrica, T.1    Lobb, R.2    Furie, B.C.3    Aronovitz, M.4    Benjamin, C.5    Hsu, Y.M.6
  • 10
    • 67651098995 scopus 로고    scopus 로고
    • Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression
    • Yang H, Lang S, Zhai Z, Li L, Kahr WH, Chen P, et al. Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood. 2009;114:425-36.
    • (2009) Blood , vol.114 , pp. 425-436
    • Yang, H.1    Lang, S.2    Zhai, Z.3    Li, L.4    Kahr, W.H.5    Chen, P.6
  • 11
    • 84905252442 scopus 로고    scopus 로고
    • Platelet membrane glycoproteins: a historical review
    • Nurden AT. Platelet membrane glycoproteins: a historical review. Semin Thromb Hemost. 2014;40:577-84.
    • (2014) Semin Thromb Hemost , vol.40 , pp. 577-584
    • Nurden, A.T.1
  • 13
    • 81255143017 scopus 로고    scopus 로고
    • Arterial thrombosis--insidious, unpredictable and deadly
    • Jackson SP. Arterial thrombosis--insidious, unpredictable and deadly. Nat Med. 2011;17:1423-36.
    • (2011) Nat Med , vol.17 , pp. 1423-1436
    • Jackson, S.P.1
  • 14
    • 84897517457 scopus 로고    scopus 로고
    • Targeting activated platelets and fibrinolysis: hitting two birds with one stone
    • Reheman A, Xu X, Reddy EC, Ni H. Targeting activated platelets and fibrinolysis: hitting two birds with one stone. Circ Res. 2014;114:1070-3.
    • (2014) Circ Res , vol.114 , pp. 1070-1073
    • Reheman, A.1    Xu, X.2    Reddy, E.C.3    Ni, H.4
  • 15
    • 84969376984 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2016 update: a report from the American Heart Association
    • Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-60.
    • (2016) Circulation , vol.133 , pp. e38-e60
    • Mozaffarian, D.1    Benjamin, E.J.2    Go, A.S.3    Arnett, D.K.4    Blaha, M.J.5
  • 16
    • 75949128633 scopus 로고    scopus 로고
    • Antiplatelet therapies for the treatment of cardiovascular disease
    • Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010;9:154-69.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 154-169
    • Michelson, A.D.1
  • 17
    • 84921578013 scopus 로고    scopus 로고
    • Novel antiplatelet agents in acute coronary syndrome
    • Franchi F, Angiolillo DJ. Novel antiplatelet agents in acute coronary syndrome. Nat Rev Cardiol. 2015;12:30-47.
    • (2015) Nat Rev Cardiol , vol.12 , pp. 30-47
    • Franchi, F.1    Angiolillo, D.J.2
  • 18
    • 84931327443 scopus 로고    scopus 로고
    • Antiplatelet drugs: which targets for which treatments?
    • Gachet C. Antiplatelet drugs: which targets for which treatments? J Thromb Haemost. 2015;13 Suppl 1:S313-22.
    • (2015) J Thromb Haemost , vol.13 , pp. S313-S322
    • Gachet, C.1
  • 19
    • 84957440989 scopus 로고    scopus 로고
    • Platelets in hemostasis and thrombosis: novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis
    • Hou Y, Carrim N, Wang Y, Gallant RC, Marshall A, Ni H. Platelets in hemostasis and thrombosis: novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis. J Biomed Res. 2015;29:437-44.
    • (2015) J Biomed Res , vol.29 , pp. 437-444
    • Hou, Y.1    Carrim, N.2    Wang, Y.3    Gallant, R.C.4    Marshall, A.5    Ni, H.6
  • 20
    • 84901951856 scopus 로고    scopus 로고
    • Phosphatidylserine exposure, microparticle formation and mitochondrial depolarisation in Glanzmann thrombasthenia platelets
    • Wang H, Bang KW, Blanchette VS, Nurden AT, Rand ML. Phosphatidylserine exposure, microparticle formation and mitochondrial depolarisation in Glanzmann thrombasthenia platelets. Thromb Haemost. 2014;111:1184-6.
    • (2014) Thromb Haemost , vol.111 , pp. 1184-1186
    • Wang, H.1    Bang, K.W.2    Blanchette, V.S.3    Nurden, A.T.4    Rand, M.L.5
  • 22
    • 84964335727 scopus 로고    scopus 로고
    • Fibronectin maintains the balance between hemostasis and thrombosis
    • Wang Y, Ni H. Fibronectin maintains the balance between hemostasis and thrombosis. Cell Mol Life Sci. 2016;73(17):3265-77. doi: 10.1007/s00018-016-2225-y.
    • (2016) Cell Mol Life Sci , vol.73 , Issue.17 , pp. 3265-3277
    • Wang, Y.1    Ni, H.2
  • 23
    • 84986563688 scopus 로고    scopus 로고
    • Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond
    • Published online
    • Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, et al. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016. Published online:1-69. doi: 10.1080/10408363.2016.1200008.
    • (2016) Crit Rev Clin Lab Sci. , pp. 1-69
    • Xu, X.R.1    Zhang, D.2    Oswald, B.E.3    Carrim, N.4    Wang, X.5    Hou, Y.6
  • 26
    • 0242300217 scopus 로고    scopus 로고
    • Antiplatelet therapy: in search of the 'magic bullet'
    • Jackson SP, Schoenwaelder SM. Antiplatelet therapy: in search of the 'magic bullet'. Nat Rev Drug Discov. 2003;2:775-89.
    • (2003) Nat Rev Drug Discov , vol.2 , pp. 775-789
    • Jackson, S.P.1    Schoenwaelder, S.M.2
  • 28
    • 84990027129 scopus 로고    scopus 로고
    • Drug Trials Snapshot Zontivity (vorapaxar)
    • Accessed 15 June 2016
    • Adminstration USFaD. Drug Trials Snapshot Zontivity (vorapaxar). 2014. http://www.fda.gov/Drugs/InformationOnDrugs/ucm423935.htm. Accessed 15 June 2016.
    • (2014)
  • 29
    • 84990031337 scopus 로고    scopus 로고
    • Accessed 15 June 2016
    • ClinicalTrials.gov. 2011. https://clinicaltrials.gov/ct2/show/NCT00527943?term=Vorapaxar&rank=5. Accessed 15 June 2016.
    • (2011)
  • 30
    • 0037145037 scopus 로고    scopus 로고
    • Integrins: bidirectional, allosteric signaling machines
    • Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673-87.
    • (2002) Cell , vol.110 , pp. 673-687
    • Hynes, R.O.1
  • 31
    • 0032400917 scopus 로고    scopus 로고
    • The selective inhibition of beta 1 and beta 7 integrin-mediated lymphocyte adhesion by bacitracin
    • Mou Y, Ni H, Wilkins JA. The selective inhibition of beta 1 and beta 7 integrin-mediated lymphocyte adhesion by bacitracin. J Immunol. 1998;161:6323-9.
    • (1998) J Immunol , vol.161 , pp. 6323-6329
    • Mou, Y.1    Ni, H.2    Wilkins, J.A.3
  • 34
    • 84963491567 scopus 로고    scopus 로고
    • Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2
    • Tamura S, Suzuki-Inoue K, Tsukiji N, Shirai T, Sasaki T, Osada M, et al. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2. Blood. 2016;127:1701-10.
    • (2016) Blood , vol.127 , pp. 1701-1710
    • Tamura, S.1    Suzuki-Inoue, K.2    Tsukiji, N.3    Shirai, T.4    Sasaki, T.5    Osada, M.6
  • 35
    • 84867391556 scopus 로고    scopus 로고
    • Crosstalk between platelets and the immune system: old systems with new discoveries
    • Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, et al. Crosstalk between platelets and the immune system: old systems with new discoveries. Adv Hematol. 2012;2012:384685.
    • (2012) Adv Hematol , vol.2012 , pp. 384685
    • Li, C.1    Li, J.2    Li, Y.3    Lang, S.4    Yougbare, I.5    Zhu, G.6
  • 38
    • 41149162116 scopus 로고    scopus 로고
    • Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis
    • Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res. 2008;78:8-17.
    • (2008) Cardiovasc Res , vol.78 , pp. 8-17
    • Siegel-Axel, D.1    Daub, K.2    Seizer, P.3    Lindemann, S.4    Gawaz, M.5
  • 40
    • 84877356252 scopus 로고    scopus 로고
    • Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis
    • Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, et al. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med. 2013;19:586-94.
    • (2013) Nat Med , vol.19 , pp. 586-594
    • Murphy, A.J.1    Bijl, N.2    Yvan-Charvet, L.3    Welch, C.B.4    Bhagwat, N.5    Reheman, A.6
  • 41
    • 84892923313 scopus 로고    scopus 로고
    • Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life
    • Hess PR, Rawnsley DR, Jakus Z, Yang Y, Sweet DT, Fu J, et al. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J Clin Invest. 2014;124:273-84.
    • (2014) J Clin Invest , vol.124 , pp. 273-284
    • Hess, P.R.1    Rawnsley, D.R.2    Jakus, Z.3    Yang, Y.4    Sweet, D.T.5    Fu, J.6
  • 42
  • 43
    • 84862702605 scopus 로고    scopus 로고
    • Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells
    • Osada M, Inoue O, Ding G, Shirai T, Ichise H, Hirayama K, et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem. 2012;287:22241-52.
    • (2012) J Biol Chem , vol.287 , pp. 22241-22252
    • Osada, M.1    Inoue, O.2    Ding, G.3    Shirai, T.4    Ichise, H.5    Hirayama, K.6
  • 44
    • 84885624688 scopus 로고    scopus 로고
    • Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
    • Herzog BH, Fu J, Wilson SJ, Hess PR, Sen A, McDaniel JM, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013;502:105-9.
    • (2013) Nature , vol.502 , pp. 105-109
    • Herzog, B.H.1    Fu, J.2    Wilson, S.J.3    Hess, P.R.4    Sen, A.5    McDaniel, J.M.6
  • 45
    • 38949178835 scopus 로고    scopus 로고
    • Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released
    • Italiano Jr JE, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008;111:1227-33.
    • (2008) Blood , vol.111 , pp. 1227-1233
    • Italiano, J.E.1    Richardson, J.L.2    Patel-Hett, S.3    Battinelli, E.4    Zaslavsky, A.5    Short, S.6
  • 46
    • 79953826916 scopus 로고    scopus 로고
    • Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli
    • Chatterjee M, Huang Z, Zhang W, Jiang L, Hultenby K, Zhu L, et al. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood. 2011;117:3907-11.
    • (2011) Blood , vol.117 , pp. 3907-3911
    • Chatterjee, M.1    Huang, Z.2    Zhang, W.3    Jiang, L.4    Hultenby, K.5    Zhu, L.6
  • 47
    • 84926312039 scopus 로고    scopus 로고
    • Maternal anti-platelet beta3 integrins impair angiogenesis and cause intracranial hemorrhage
    • Yougbare I, Lang S, Yang H, Chen P, Zhao X, Tai WS, et al. Maternal anti-platelet beta3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Invest. 2015;125:1545-56.
    • (2015) J Clin Invest , vol.125 , pp. 1545-1556
    • Yougbare, I.1    Lang, S.2    Yang, H.3    Chen, P.4    Zhao, X.5    Tai, W.S.6
  • 48
    • 80555134759 scopus 로고    scopus 로고
    • The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies
    • Li C, Piran S, Chen P, Lang S, Zarpellon A, Jin JW, et al. The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest. 2011;121:4537-47.
    • (2011) J Clin Invest , vol.121 , pp. 4537-4547
    • Li, C.1    Piran, S.2    Chen, P.3    Lang, S.4    Zarpellon, A.5    Jin, J.W.6
  • 49
    • 84990030694 scopus 로고    scopus 로고
    • Natural killer cells contribute to pathophysiology of placenta leading to miscarriage in fetal and neonatal alloimmune thrombocytopenia
    • Yougbare I, Wei-She T, Zdravic D, Chen P, Zhu G, Leong-Poi H, et al. Natural killer cells contribute to pathophysiology of placenta leading to miscarriage in fetal and neonatal alloimmune thrombocytopenia. Blood. 2015;126:2254.
    • (2015) Blood , vol.126 , pp. 2254
    • Yougbare, I.1    Wei-She, T.2    Zdravic, D.3    Chen, P.4    Zhu, G.5    Leong-Poi, H.6
  • 50
    • 84871485133 scopus 로고    scopus 로고
    • The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination
    • Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012;2:1091-9.
    • (2012) Cancer Discov , vol.2 , pp. 1091-1099
    • Labelle, M.1    Hynes, R.O.2
  • 51
    • 84905014848 scopus 로고    scopus 로고
    • Platelets guide the formation of early metastatic niches
    • Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A. 2014;111:E3053-61.
    • (2014) Proc Natl Acad Sci U S A , vol.111 , pp. E3053-E3061
    • Labelle, M.1    Begum, S.2    Hynes, R.O.3
  • 52
    • 84940202183 scopus 로고    scopus 로고
    • Platelets at the interface of thrombosis, inflammation, and cancer
    • Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126:582-8.
    • (2015) Blood , vol.126 , pp. 582-588
    • Franco, A.T.1    Corken, A.2    Ware, J.3
  • 53
    • 33846235429 scopus 로고    scopus 로고
    • Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet
    • Luo SZ, Mo X, Afshar-Kharghan V, Srinivasan S, Lopez JA, Li R. Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet. Blood. 2007;109:603-9.
    • (2007) Blood , vol.109 , pp. 603-609
    • Luo, S.Z.1    Mo, X.2    Afshar-Kharghan, V.3    Srinivasan, S.4    Lopez, J.A.5    Li, R.6
  • 54
    • 34250007429 scopus 로고    scopus 로고
    • The growing complexity of platelet aggregation
    • Jackson SP. The growing complexity of platelet aggregation. Blood. 2007;109:5087-95.
    • (2007) Blood , vol.109 , pp. 5087-5095
    • Jackson, S.P.1
  • 55
    • 34250818668 scopus 로고    scopus 로고
    • Adhesion mechanisms in platelet function
    • Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res. 2007;100:1673-85.
    • (2007) Circ Res , vol.100 , pp. 1673-1685
    • Ruggeri, Z.M.1    Mendolicchio, G.L.2
  • 56
    • 0037119003 scopus 로고    scopus 로고
    • Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain
    • Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, et al. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science. 2002;297:1176-9.
    • (2002) Science , vol.297 , pp. 1176-1179
    • Huizinga, E.G.1    Tsuji, S.2    Romijn, R.A.3    Schiphorst, M.E.4    Groot, P.G.5    Sixma, J.J.6
  • 57
    • 84947997089 scopus 로고    scopus 로고
    • Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice
    • Verhenne S, Denorme F, Libbrecht S, Vandenbulcke A, Pareyn I, Deckmyn H, et al. Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice. Blood. 2015;126:1715-22.
    • (2015) Blood , vol.126 , pp. 1715-1722
    • Verhenne, S.1    Denorme, F.2    Libbrecht, S.3    Vandenbulcke, A.4    Pareyn, I.5    Deckmyn, H.6
  • 58
    • 0038157329 scopus 로고    scopus 로고
    • Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation
    • Dumas JJ, Kumar R, Seehra J, Somers WS, Mosyak L. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science. 2003;301:222-6.
    • (2003) Science , vol.301 , pp. 222-226
    • Dumas, J.J.1    Kumar, R.2    Seehra, J.3    Somers, W.S.4    Mosyak, L.5
  • 59
    • 0037815126 scopus 로고    scopus 로고
    • Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha
    • Celikel R, McClintock RA, Roberts JR, Mendolicchio GL, Ware J, Varughese KI, et al. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science. 2003;301:218-21.
    • (2003) Science , vol.301 , pp. 218-221
    • Celikel, R.1    McClintock, R.A.2    Roberts, J.R.3    Mendolicchio, G.L.4    Ware, J.5    Varughese, K.I.6
  • 60
    • 84882690197 scopus 로고    scopus 로고
    • The GPIb-IX-V Complex
    • In: Michelson AD, editor. Platelets. 3rd ed.
    • Andrews RK, Berndt MC. The GPIb-IX-V Complex. In: Michelson AD, editor. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier; 2013. p. 195-213.
    • (2013) Amsterdam: Academic Press/Elsevier , pp. 195-213
    • Andrews, R.K.1    Berndt, M.C.2
  • 61
    • 0035895962 scopus 로고    scopus 로고
    • Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets
    • De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem. 2001;276:4692-8.
    • (2001) J Biol Chem , vol.276 , pp. 4692-4698
    • Candia, E.1    Hall, S.W.2    Rutella, S.3    Landolfi, R.4    Andrews, R.K.5    Cristofaro, R.6
  • 64
    • 0041703023 scopus 로고    scopus 로고
    • Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor
    • Jurk K, Clemetson KJ, de Groot PG, Brodde MF, Steiner M, Savion N, et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J. 2003;17:1490-2.
    • (2003) FASEB J , vol.17 , pp. 1490-1492
    • Jurk, K.1    Clemetson, K.J.2    Groot, P.G.3    Brodde, M.F.4    Steiner, M.5    Savion, N.6
  • 65
    • 0037127251 scopus 로고    scopus 로고
    • Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin
    • Baglia FA, Badellino KO, Li CQ, Lopez JA, Walsh PN. Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem. 2002;277:1662-8.
    • (2002) J Biol Chem , vol.277 , pp. 1662-1668
    • Baglia, F.A.1    Badellino, K.O.2    Li, C.Q.3    Lopez, J.A.4    Walsh, P.N.5
  • 66
    • 0034725612 scopus 로고    scopus 로고
    • Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation
    • Bradford HN, Pixley RA, Colman RW. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem. 2000;275:22756-63.
    • (2000) J Biol Chem. , vol.275 , pp. 22756-22763
    • Bradford, H.N.1    Pixley, R.A.2    Colman, R.W.3
  • 67
    • 54049130877 scopus 로고    scopus 로고
    • The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface
    • Weeterings C, de Groot PG, Adelmeijer J, Lisman T. The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood. 2008;112:3227-33.
    • (2008) Blood , vol.112 , pp. 3227-3233
    • Weeterings, C.1    Groot, P.G.2    Adelmeijer, J.3    Lisman, T.4
  • 68
    • 0242580951 scopus 로고    scopus 로고
    • High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib
    • Chavakis T, Santoso S, Clemetson KJ, Sachs UJ, Isordia-Salas I, Pixley RA, et al. High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib. J Biol Chem. 2003;278:45375-81.
    • (2003) J Biol Chem , vol.278 , pp. 45375-45381
    • Chavakis, T.1    Santoso, S.2    Clemetson, K.J.3    Sachs, U.J.4    Isordia-Salas, I.5    Pixley, R.A.6
  • 69
  • 70
    • 84937850992 scopus 로고    scopus 로고
    • Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4
    • Kaplan ZS, Zarpellon A, Alwis I, Yuan Y, McFadyen J, Ghasemzadeh M, et al. Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4. Nat Commun. 2015;6:7835.
    • (2015) Nat Commun , vol.6 , pp. 7835
    • Kaplan, Z.S.1    Zarpellon, A.2    Alwis, I.3    Yuan, Y.4    McFadyen, J.5    Ghasemzadeh, M.6
  • 71
    • 0034679329 scopus 로고    scopus 로고
    • Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)
    • Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med. 2000;192:193-204.
    • (2000) J Exp Med , vol.192 , pp. 193-204
    • Simon, D.I.1    Chen, Z.2    Xu, H.3    Li, C.Q.4    Dong, J.5    McIntire, L.V.6
  • 73
    • 84937605469 scopus 로고    scopus 로고
    • Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
    • Li J, van der Wal DE, Zhu G, Xu M, Yougbare I, Ma L, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun. 2015;6:7737.
    • (2015) Nat Commun , vol.6 , pp. 7737
    • Li, J.1    Wal, D.E.2    Zhu, G.3    Xu, M.4    Yougbare, I.5    Ma, L.6
  • 74
    • 84897390496 scopus 로고    scopus 로고
    • Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage
    • Li J, Callum JL, Lin Y, Zhou Y, Zhu G, Ni H. Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage. Haematologica. 2014;99:e61-3.
    • (2014) Haematologica , vol.99 , pp. e61-e63
    • Li, J.1    Callum, J.L.2    Lin, Y.3    Zhou, Y.4    Zhu, G.5    Ni, H.6
  • 75
    • 84867144010 scopus 로고    scopus 로고
    • Inhibitors of the interaction between von Willebrand factor and platelet GPIb/IX/V
    • Gresele P, Momi S. Inhibitors of the interaction between von Willebrand factor and platelet GPIb/IX/V. Handb Exp Pharmacol. 2012;(210):287-309.
    • (2012) Handb Exp Pharmacol , Issue.210 , pp. 287-309
    • Gresele, P.1    Momi, S.2
  • 76
    • 79960058122 scopus 로고    scopus 로고
    • Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs
    • Ulrichts H, Silence K, Schoolmeester A, de Jaegere P, Rossenu S, Roodt J, et al. Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs. Blood. 2011;118:757-65.
    • (2011) Blood , vol.118 , pp. 757-765
    • Ulrichts, H.1    Silence, K.2    Schoolmeester, A.3    Jaegere, P.4    Rossenu, S.5    Roodt, J.6
  • 80
    • 84962074417 scopus 로고    scopus 로고
    • Thrombotic microangiopathy: caplacizumab accelerates resolution of acute acquired TTP
    • Lammle B. Thrombotic microangiopathy: caplacizumab accelerates resolution of acute acquired TTP. Nat Rev Nephrol. 2016;12:259-60.
    • (2016) Nat Rev Nephrol , vol.12 , pp. 259-260
    • Lammle, B.1
  • 81
    • 84959308771 scopus 로고    scopus 로고
    • Willebrand factor--a new target for TTP treatment?
    • Von VA. Willebrand factor--a new target for TTP treatment? N Engl J Med. 2016;374:583-5.
    • (2016) N Engl J Med , vol.374 , pp. 583-585
    • Von, V.A.1
  • 82
    • 84906806362 scopus 로고    scopus 로고
    • Management of thrombotic thrombocytopenic purpura: current perspectives
    • Blombery P, Scully M. Management of thrombotic thrombocytopenic purpura: current perspectives. J Blood Med. 2014;5:15-23.
    • (2014) J Blood Med , vol.5 , pp. 15-23
    • Blombery, P.1    Scully, M.2
  • 83
    • 84893185728 scopus 로고    scopus 로고
    • Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis
    • Lei X, Reheman A, Hou Y, Zhou H, Wang Y, Marshall AH, et al. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thromb Haemost. 2014;111:279-89.
    • (2014) Thromb Haemost , vol.111 , pp. 279-289
    • Lei, X.1    Reheman, A.2    Hou, Y.3    Zhou, H.4    Wang, Y.5    Marshall, A.H.6
  • 84
    • 84933050866 scopus 로고    scopus 로고
    • The first in vitro and in vivo assessment of anfibatide, a novel glycoprotein ib antagonist, in mice and in a phase i human clinical trial
    • Hou Y, Li BX, Dai X, Yang Z, Qian F, Zhang G, et al. The first in vitro and in vivo assessment of anfibatide, a novel glycoprotein ib antagonist, in mice and in a phase i human clinical trial. Blood. 2013;122:577.
    • (2013) Blood , vol.122 , pp. 577
    • Hou, Y.1    Li, B.X.2    Dai, X.3    Yang, Z.4    Qian, F.5    Zhang, G.6
  • 85
    • 84986628832 scopus 로고    scopus 로고
    • First ex vivo and in vivo assessment of anfibatide, a novel glycoprotein Ib-IV-V complex antagonist, in healthy human volunteers in phase I clinical trial
    • Li B, Dai X, Yang Z, Qian F, Zhang G, Xu Z, et al. First ex vivo and in vivo assessment of anfibatide, a novel glycoprotein Ib-IV-V complex antagonist, in healthy human volunteers in phase I clinical trial. J Thromb Haemost. 2013;11 Suppl 2:23.
    • (2013) J Thromb Haemost , vol.11 , pp. 23
    • Li, B.1    Dai, X.2    Yang, Z.3    Qian, F.4    Zhang, G.5    Xu, Z.6
  • 86
    • 80052210855 scopus 로고    scopus 로고
    • Ischaemic stroke: a thrombo-inflammatory disease?
    • Nieswandt B, Kleinschnitz C, Stoll G. Ischaemic stroke: a thrombo-inflammatory disease? J Physiol. 2011;589:4115-23.
    • (2011) J Physiol , vol.589 , pp. 4115-4123
    • Nieswandt, B.1    Kleinschnitz, C.2    Stoll, G.3
  • 87
    • 55749101354 scopus 로고    scopus 로고
    • Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment
    • Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008;112:3555-62.
    • (2008) Blood , vol.112 , pp. 3555-3562
    • Stoll, G.1    Kleinschnitz, C.2    Nieswandt, B.3
  • 88
    • 34247643257 scopus 로고    scopus 로고
    • Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding
    • Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007;115:2323-30.
    • (2007) Circulation , vol.115 , pp. 2323-2330
    • Kleinschnitz, C.1    Pozgajova, M.2    Pham, M.3    Bendszus, M.4    Nieswandt, B.5    Stoll, G.6
  • 90
    • 54949095069 scopus 로고    scopus 로고
    • The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons
    • Fontayne A, Meiring M, Lamprecht S, Roodt J, Demarsin E, Barbeaux P, et al. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Thromb Haemost. 2008;100:670-7.
    • (2008) Thromb Haemost , vol.100 , pp. 670-677
    • Fontayne, A.1    Meiring, M.2    Lamprecht, S.3    Roodt, J.4    Demarsin, E.5    Barbeaux, P.6
  • 91
    • 33645540605 scopus 로고    scopus 로고
    • Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis
    • Hennan JK, Swillo RE, Morgan GA, Leik CE, Brooks JM, Shaw GD, et al. Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis. Thromb Haemost. 2006;95:469-75.
    • (2006) Thromb Haemost , vol.95 , pp. 469-475
    • Hennan, J.K.1    Swillo, R.E.2    Morgan, G.A.3    Leik, C.E.4    Brooks, J.M.5    Shaw, G.D.6
  • 92
    • 84990054744 scopus 로고    scopus 로고
    • Novel monoclonal antibodies against platelet GPIb-alpha: potential anti-thrombotic drugs and research reagents for study of thrombosis and hemostasis
    • US8323652
    • Ni H, Zhu G. Novel monoclonal antibodies against platelet GPIb-alpha: potential anti-thrombotic drugs and research reagents for study of thrombosis and hemostasis. 2012. US8323652.
    • (2012)
    • Ni, H.1    Zhu, G.2
  • 93
    • 84925505672 scopus 로고    scopus 로고
    • Impact of the PI3-kinase/Akt pathway on ITAM and hemITAM receptors: haemostasis, platelet activation and antithrombotic therapy
    • Moroi AJ, Watson SP. Impact of the PI3-kinase/Akt pathway on ITAM and hemITAM receptors: haemostasis, platelet activation and antithrombotic therapy. Biochem Pharmacol. 2015;94:186-94.
    • (2015) Biochem Pharmacol , vol.94 , pp. 186-194
    • Moroi, A.J.1    Watson, S.P.2
  • 95
    • 84940023454 scopus 로고    scopus 로고
    • Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation
    • Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood. 2015;126:683-91.
    • (2015) Blood , vol.126 , pp. 683-691
    • Mammadova-Bach, E.1    Ollivier, V.2    Loyau, S.3    Schaff, M.4    Dumont, B.5    Favier, R.6
  • 96
    • 73449086712 scopus 로고    scopus 로고
    • Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke
    • Bigalke B, Stellos K, Geisler T, Kremmer E, Seizer P, May AE, et al. Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke. Eur J Neurol. 2010;17:111-7.
    • (2010) Eur J Neurol , vol.17 , pp. 111-117
    • Bigalke, B.1    Stellos, K.2    Geisler, T.3    Kremmer, E.4    Seizer, P.5    May, A.E.6
  • 97
    • 84979911429 scopus 로고    scopus 로고
    • Beyond antiplatelets: the role of glycoprotein VI in ischemic stroke
    • Induruwa I, Jung SM, Warburton EA. Beyond antiplatelets: the role of glycoprotein VI in ischemic stroke. Int J Stroke. 2016. doi: 10.1177/1747493016654532.
    • (2016) Int J Stroke
    • Induruwa, I.1    Jung, S.M.2    Warburton, E.A.3
  • 98
    • 79251631764 scopus 로고    scopus 로고
    • Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke
    • Al-Tamimi M, Gardiner EE, Thom JY, Shen Y, Cooper MN, Hankey GJ, et al. Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke. Stroke. 2011;42:498-500.
    • (2011) Stroke , vol.42 , pp. 498-500
    • Al-Tamimi, M.1    Gardiner, E.E.2    Thom, J.Y.3    Shen, Y.4    Cooper, M.N.5    Hankey, G.J.6
  • 99
    • 78149237097 scopus 로고    scopus 로고
    • Combating innate inflammation: a new paradigm for acute treatment of stroke?
    • Stoll G, Kleinschnitz C, Nieswandt B. Combating innate inflammation: a new paradigm for acute treatment of stroke? Ann N Y Acad Sci. 2010;1207:149-54.
    • (2010) Ann N Y Acad Sci , vol.1207 , pp. 149-154
    • Stoll, G.1    Kleinschnitz, C.2    Nieswandt, B.3
  • 101
    • 84904675274 scopus 로고    scopus 로고
    • Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway
    • Stegner D, Haining EJ, Nieswandt B. Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway. Arterioscler Thromb Vasc Biol. 2014;34:1615-20.
    • (2014) Arterioscler Thromb Vasc Biol , vol.34 , pp. 1615-1620
    • Stegner, D.1    Haining, E.J.2    Nieswandt, B.3
  • 102
    • 84867888747 scopus 로고    scopus 로고
    • Platelet GPVI: a target for antithrombotic therapy?!
    • Dutting S, Bender M, Nieswandt B. Platelet GPVI: a target for antithrombotic therapy?! Trends Pharmacol Sci. 2012;33:583-90.
    • (2012) Trends Pharmacol Sci , vol.33 , pp. 583-590
    • Dutting, S.1    Bender, M.2    Nieswandt, B.3
  • 104
    • 84880753729 scopus 로고    scopus 로고
    • The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke
    • Goebel S, Li Z, Vogelmann J, Holthoff HP, Degen H, Hermann DM, et al. The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke. PLoS One. 2013;8:e66960.
    • (2013) PLoS One , vol.8
    • Goebel, S.1    Li, Z.2    Vogelmann, J.3    Holthoff, H.P.4    Degen, H.5    Hermann, D.M.6
  • 105
    • 85027958733 scopus 로고    scopus 로고
    • Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans
    • Ungerer M, Rosport K, Bultmann A, Piechatzek R, Uhland K, Schlieper P, et al. Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation. 2011;123:1891-9.
    • (2011) Circulation , vol.123 , pp. 1891-1899
    • Ungerer, M.1    Rosport, K.2    Bultmann, A.3    Piechatzek, R.4    Uhland, K.5    Schlieper, P.6
  • 106
    • 84990048770 scopus 로고    scopus 로고
    • Accessed 15 June 2016
    • ClinicalTrials.gov. 2015. https://clinicaltrials.gov/ct2/show/NCT01645306?term=Revacept&rank=1. Accessed 15 June 2016.
    • (2015)
  • 107
    • 77949363102 scopus 로고    scopus 로고
    • Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI
    • Ono K, Ueda H, Yoshizawa Y, Akazawa D, Tanimura R, Shimada I, et al. Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI. J Med Chem. 2010;53:2087-93.
    • (2010) J Med Chem , vol.53 , pp. 2087-2093
    • Ono, K.1    Ueda, H.2    Yoshizawa, Y.3    Akazawa, D.4    Tanimura, R.5    Shimada, I.6
  • 108
    • 68149163242 scopus 로고    scopus 로고
    • Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro
    • Muzard J, Bouabdelli M, Zahid M, Ollivier V, Lacapere JJ, Jandrot-Perrus M, et al. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro. FEBS J. 2009;276:4207-22.
    • (2009) FEBS J , vol.276 , pp. 4207-4222
    • Muzard, J.1    Bouabdelli, M.2    Zahid, M.3    Ollivier, V.4    Lacapere, J.J.5    Jandrot-Perrus, M.6
  • 109
    • 0037031906 scopus 로고    scopus 로고
    • Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling
    • Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002;110:599-611.
    • (2002) Cell , vol.110 , pp. 599-611
    • Takagi, J.1    Petre, B.M.2    Walz, T.3    Springer, T.A.4
  • 110
    • 0038644597 scopus 로고    scopus 로고
    • Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations
    • Li R, Mitra N, Gratkowski H, Vilaire G, Litvinov R, Nagasami C, et al. Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations. Science. 2003;300:795-8.
    • (2003) Science , vol.300 , pp. 795-798
    • Li, R.1    Mitra, N.2    Gratkowski, H.3    Vilaire, G.4    Litvinov, R.5    Nagasami, C.6
  • 112
    • 0037031551 scopus 로고    scopus 로고
    • A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face
    • Vinogradova O, Velyvis A, Velyviene A, Hu B, Haas T, Plow E, et al. A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell. 2002;110:587-97.
    • (2002) Cell , vol.110 , pp. 587-597
    • Vinogradova, O.1    Velyvis, A.2    Velyviene, A.3    Hu, B.4    Haas, T.5    Plow, E.6
  • 113
    • 0033838314 scopus 로고    scopus 로고
    • Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen
    • Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 2000;106:385-92.
    • (2000) J Clin Invest , vol.106 , pp. 385-392
    • Ni, H.1    Denis, C.V.2    Subbarao, S.3    Degen, J.L.4    Sato, T.N.5    Hynes, R.O.6
  • 114
    • 0033592610 scopus 로고    scopus 로고
    • Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function
    • Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, Phillips DR. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature. 1999;401:808-11.
    • (1999) Nature , vol.401 , pp. 808-811
    • Law, D.A.1    DeGuzman, F.R.2    Heiser, P.3    Ministri-Madrid, K.4    Killeen, N.5    Phillips, D.R.6
  • 115
    • 0032590042 scopus 로고    scopus 로고
    • Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
    • Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999;103:229-38.
    • (1999) J Clin Invest , vol.103 , pp. 229-238
    • Hodivala-Dilke, K.M.1    McHugh, K.P.2    Tsakiris, D.A.3    Rayburn, H.4    Crowley, D.5    Ullman-Cullere, M.6
  • 116
    • 61849083539 scopus 로고    scopus 로고
    • Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor
    • Reheman A, Yang H, Zhu G, Jin W, He F, Spring CM, et al. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood. 2009;113:1809-17.
    • (2009) Blood , vol.113 , pp. 1809-1817
    • Reheman, A.1    Yang, H.2    Zhu, G.3    Jin, W.4    He, F.5    Spring, C.M.6
  • 117
    • 23844514494 scopus 로고    scopus 로고
    • Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation
    • Reheman A, Gross P, Yang H, Chen P, Allen D, Leytin V, et al. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost. 2005;3:875-83.
    • (2005) J Thromb Haemost , vol.3 , pp. 875-883
    • Reheman, A.1    Gross, P.2    Yang, H.3    Chen, P.4    Allen, D.5    Leytin, V.6
  • 118
  • 119
    • 0030863733 scopus 로고    scopus 로고
    • Clinical pharmacology of eptifibatide
    • Phillips DR, Scarborough RM. Clinical pharmacology of eptifibatide. Am J Cardiol. 1997;80:11B-20B.
    • (1997) Am J Cardiol , vol.80 , pp. 11B-20B
    • Phillips, D.R.1    Scarborough, R.M.2
  • 120
    • 0027968662 scopus 로고
    • Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp
    • Egbertson MS, Chang CT, Duggan ME, Gould RJ, Halczenko W, Hartman GD, et al. Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. J Med Chem. 1994;37:2537-51.
    • (1994) J Med Chem , vol.37 , pp. 2537-2551
    • Egbertson, M.S.1    Chang, C.T.2    Duggan, M.E.3    Gould, R.J.4    Halczenko, W.5    Hartman, G.D.6
  • 121
    • 80052626426 scopus 로고    scopus 로고
    • Anti-platelet therapy: glycoprotein IIb-IIIa antagonists
    • Schneider DJ. Anti-platelet therapy: glycoprotein IIb-IIIa antagonists. Br J Clin Pharmacol. 2011;72:672-82.
    • (2011) Br J Clin Pharmacol , vol.72 , pp. 672-682
    • Schneider, D.J.1
  • 122
    • 84931294411 scopus 로고    scopus 로고
    • alphaIIbbeta3: structure and function
    • Coller BS. alphaIIbbeta3: structure and function. J Thromb Haemost. 2015;13 Suppl 1:S17-25.
    • (2015) J Thromb Haemost , vol.13 , pp. S17-25
    • Coller, B.S.1
  • 125
    • 4644272216 scopus 로고    scopus 로고
    • A novel adaptation of the integrin PSI domain revealed from its crystal structure
    • Xiong JP, Stehle T, Goodman SL, Arnaout MA. A novel adaptation of the integrin PSI domain revealed from its crystal structure. J Biol Chem. 2004;279:40252-4.
    • (2004) J Biol Chem , vol.279 , pp. 40252-40254
    • Xiong, J.P.1    Stehle, T.2    Goodman, S.L.3    Arnaout, M.A.4
  • 126
    • 0035831488 scopus 로고    scopus 로고
    • Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin beta2 subunit that restrain activation of the integrin alpha(X)beta(2)
    • Zang Q, Springer TA. Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin beta2 subunit that restrain activation of the integrin alpha(X)beta(2). J Biol Chem. 2001;276:6922-9.
    • (2001) J Biol Chem , vol.276 , pp. 6922-6929
    • Zang, Q.1    Springer, T.A.2
  • 127
    • 0032478739 scopus 로고    scopus 로고
    • Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain
    • Ni H, Li A, Simonsen N, Wilkins JA. Integrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain. J Biol Chem. 1998;273:7981-7.
    • (1998) J Biol Chem , vol.273 , pp. 7981-7987
    • Ni, H.1    Li, A.2    Simonsen, N.3    Wilkins, J.A.4
  • 128
    • 0034704162 scopus 로고    scopus 로고
    • A redox site involved in integrin activation
    • Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem. 2000;275:39964-72.
    • (2000) J Biol Chem , vol.275 , pp. 39964-39972
    • Yan, B.1    Smith, J.W.2
  • 129
    • 0037435609 scopus 로고    scopus 로고
    • Redox control of platelet aggregation
    • Essex DW, Li M. Redox control of platelet aggregation. Biochemistry. 2003;42:129-36.
    • (2003) Biochemistry , vol.42 , pp. 129-136
    • Essex, D.W.1    Li, M.2
  • 130
    • 79958068817 scopus 로고    scopus 로고
    • Vicinal thiols are required for activation of the alphaIIbbeta3 platelet integrin
    • Manickam N, Ahmad SS, Essex DW. Vicinal thiols are required for activation of the alphaIIbbeta3 platelet integrin. J Thromb Haemost. 2011;9:1207-15.
    • (2011) J Thromb Haemost , vol.9 , pp. 1207-1215
    • Manickam, N.1    Ahmad, S.S.2    Essex, D.W.3
  • 131
    • 84888229791 scopus 로고    scopus 로고
    • Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the alphaIIbbeta3 integrin
    • Wang L, Wu Y, Zhou J, Ahmad SS, Mutus B, Garbi N, et al. Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the alphaIIbbeta3 integrin. Blood. 2013;122:3642-50.
    • (2013) Blood , vol.122 , pp. 3642-3650
    • Wang, L.1    Wu, Y.2    Zhou, J.3    Ahmad, S.S.4    Mutus, B.5    Garbi, N.6
  • 132
    • 84986548114 scopus 로고    scopus 로고
    • Integrin PSI domain has endogenous thiol isomerase function and is a novel target for anti-thrombotic therapy
    • Carrim N, Zhu G, Reddy E, Xu M, Xu X, Wang Y, et al. Integrin PSI domain has endogenous thiol isomerase function and is a novel target for anti-thrombotic therapy. J Thromb Haemost. 2015;13(Supplement S2):60.
    • (2015) J Thromb Haemost , vol.13 , pp. 60
    • Carrim, N.1    Zhu, G.2    Reddy, E.3    Xu, M.4    Xu, X.5    Wang, Y.6
  • 133
    • 84897567751 scopus 로고    scopus 로고
    • Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets
    • Wang X, Palasubramaniam J, Gkanatsas Y, Hohmann JD, Westein E, Kanojia R, et al. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets. Circ Res. 2014;114:1083-93.
    • (2014) Circ Res , vol.114 , pp. 1083-1093
    • Wang, X.1    Palasubramaniam, J.2    Gkanatsas, Y.3    Hohmann, J.D.4    Westein, E.5    Kanojia, R.6
  • 134
    • 84956924316 scopus 로고    scopus 로고
    • A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation
    • Fuentes RE, Zaitsev S, Ahn HS, Hayes V, Kowalska M, Lambert MP, et al. A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation. J Clin Invest. 2016;126:483-94.
    • (2016) J Clin Invest , vol.126 , pp. 483-494
    • Fuentes, R.E.1    Zaitsev, S.2    Ahn, H.S.3    Hayes, V.4    Kowalska, M.5    Lambert, M.P.6
  • 135
    • 84881093501 scopus 로고    scopus 로고
    • Integrin alpha6beta1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis
    • Schaff M, Tang C, Maurer E, Bourdon C, Receveur N, Eckly A, et al. Integrin alpha6beta1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation. 2013;128:541-52.
    • (2013) Circulation , vol.128 , pp. 541-552
    • Schaff, M.1    Tang, C.2    Maurer, E.3    Bourdon, C.4    Receveur, N.5    Eckly, A.6
  • 136
    • 58849165421 scopus 로고    scopus 로고
    • Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism
    • Miller MW, Basra S, Kulp DW, Billings PC, Choi S, Beavers MP, et al. Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism. Proc Natl Acad Sci U S A. 2009;106:719-24.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 719-724
    • Miller, M.W.1    Basra, S.2    Kulp, D.W.3    Billings, P.C.4    Choi, S.5    Beavers, M.P.6
  • 137
    • 0034663794 scopus 로고    scopus 로고
    • Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin
    • Marcinkiewicz C, Lobb RR, Marcinkiewicz MM, Daniel JL, Smith JB, Dangelmaier C, et al. Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. Biochemistry. 2000;39:9859-67.
    • (2000) Biochemistry , vol.39 , pp. 9859-9867
    • Marcinkiewicz, C.1    Lobb, R.R.2    Marcinkiewicz, M.M.3    Daniel, J.L.4    Smith, J.B.5    Dangelmaier, C.6
  • 138
    • 84873607002 scopus 로고    scopus 로고
    • Identification of alpha2beta1 integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae
    • Arlinghaus FT, Momic T, Ammar NA, Shai E, Spectre G, Varon D, et al. Identification of alpha2beta1 integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae. Toxicon. 2013;64:96-105.
    • (2013) Toxicon , vol.64 , pp. 96-105
    • Arlinghaus, F.T.1    Momic, T.2    Ammar, N.A.3    Shai, E.4    Spectre, G.5    Varon, D.6
  • 139
    • 0023889506 scopus 로고
    • Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets
    • Piotrowicz RS, Orchekowski RP, Nugent DJ, Yamada KY, Kunicki TJ. Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets. J Cell Biol. 1988;106:1359-64.
    • (1988) J Cell Biol , vol.106 , pp. 1359-1364
    • Piotrowicz, R.S.1    Orchekowski, R.P.2    Nugent, D.J.3    Yamada, K.Y.4    Kunicki, T.J.5
  • 140
    • 74749106019 scopus 로고    scopus 로고
    • Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis
    • Przyklenk K, Frelinger 3rd AL, Linden MD, Whittaker P, Li Y, Barnard MR, et al. Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis. J Thromb Haemost. 2010;8:331-40.
    • (2010) J Thromb Haemost , vol.8 , pp. 331-340
    • Przyklenk, K.1    Frelinger, A.L.2    Linden, M.D.3    Whittaker, P.4    Li, Y.5    Barnard, M.R.6
  • 141
    • 84862741838 scopus 로고    scopus 로고
    • The platelet "sugar high" in diabetes
    • Ni H. The platelet "sugar high" in diabetes. Blood. 2012;119:5949-51.
    • (2012) Blood , vol.119 , pp. 5949-5951
    • Ni, H.1
  • 142
    • 84969776766 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 receptor activation attenuates platelet aggregation and thrombosis
    • Cameron-Vendrig A, Reheman A, Siraj MA, Xu XR, Wang Y, Lei X, et al. Glucagon-like peptide 1 receptor activation attenuates platelet aggregation and thrombosis. Diabetes. 2016;65:1714-23.
    • (2016) Diabetes , vol.65 , pp. 1714-1723
    • Cameron-Vendrig, A.1    Reheman, A.2    Siraj, M.A.3    Xu, X.R.4    Wang, Y.5    Lei, X.6
  • 143
    • 84890572455 scopus 로고    scopus 로고
    • Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials
    • Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E. Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab. 2014;16:38-47.
    • (2014) Diabetes Obes Metab , vol.16 , pp. 38-47
    • Monami, M.1    Dicembrini, I.2    Nardini, C.3    Fiordelli, I.4    Mannucci, E.5
  • 144
    • 84902104685 scopus 로고    scopus 로고
    • Thrombosis: tangled up in NETs
    • Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123:2768-76.
    • (2014) Blood , vol.123 , pp. 2768-2776
    • Martinod, K.1    Wagner, D.D.2
  • 145
    • 0033574172 scopus 로고    scopus 로고
    • Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model
    • Kumar A, Villani MP, Patel UK, Keith Jr JC, Schaub RG. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation. 1999;99:1363-9.
    • (1999) Circulation , vol.99 , pp. 1363-1369
    • Kumar, A.1    Villani, M.P.2    Patel, U.K.3    Keith, J.C.4    Schaub, R.G.5
  • 146
    • 38749140235 scopus 로고    scopus 로고
    • Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis
    • Bedard PW, Clerin V, Sushkova N, Tchernychev B, Antrilli T, Resmini C, et al. Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis. J Pharmacol Exp Ther. 2008;324:497-506.
    • (2008) J Pharmacol Exp Ther , vol.324 , pp. 497-506
    • Bedard, P.W.1    Clerin, V.2    Sushkova, N.3    Tchernychev, B.4    Antrilli, T.5    Resmini, C.6
  • 147
    • 38949147126 scopus 로고    scopus 로고
    • Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation
    • Meier TR, Myers Jr DD, Wrobleski SK, Zajkowski PJ, Hawley AE, Bedard PW, et al. Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost. 2008;99:343-51.
    • (2008) Thromb Haemost , vol.99 , pp. 343-351
    • Meier, T.R.1    Myers, D.D.2    Wrobleski, S.K.3    Zajkowski, P.J.4    Hawley, A.E.5    Bedard, P.W.6
  • 148
    • 84882613761 scopus 로고    scopus 로고
    • Novel antiplatelet therapies
    • In: Michelson AD, editor. Platelets. 3rd ed.
    • Kolandaivelu K, Bhatt DL. Novel antiplatelet therapies. In: Michelson AD, editor. Platelets. 3rd ed. Amsterdam: Academic Press/Elsevier; 2013. p. 1185-213.
    • (2013) Amsterdam: Academic Press/Elsevier , pp. 1185-1213
    • Kolandaivelu, K.1    Bhatt, D.L.2
  • 149
    • 0347535965 scopus 로고    scopus 로고
    • Soluble CD40 ligand in acute coronary syndromes
    • Conde ID, Kleiman NS. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003;348:2575-7.
    • (2003) N Engl J Med , vol.348 , pp. 2575-2577
    • Conde, I.D.1    Kleiman, N.S.2
  • 150
    • 0035824895 scopus 로고    scopus 로고
    • CD40 signaling and plaque instability
    • Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res. 2001;89:1092-103.
    • (2001) Circ Res , vol.89 , pp. 1092-1103
    • Schonbeck, U.1    Libby, P.2
  • 151
    • 84960091403 scopus 로고    scopus 로고
    • Essential roles of toll-like receptors in atherosclerosis
    • Lin J, Kakkar V, Lu X. Essential roles of toll-like receptors in atherosclerosis. Curr Med Chem. 2016;23:431-54.
    • (2016) Curr Med Chem , vol.23 , pp. 431-454
    • Lin, J.1    Kakkar, V.2    Lu, X.3
  • 152
    • 84931268779 scopus 로고    scopus 로고
    • The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis
    • Hovland A, Jonasson L, Garred P, Yndestad A, Aukrust P, Lappegard KT, et al. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis. Atherosclerosis. 2015;241:480-94.
    • (2015) Atherosclerosis , vol.241 , pp. 480-494
    • Hovland, A.1    Jonasson, L.2    Garred, P.3    Yndestad, A.4    Aukrust, P.5    Lappegard, K.T.6
  • 154
    • 84990055362 scopus 로고    scopus 로고
    • Methods for inhibiting platelet aggregation using glp-1 receptor agonists
    • WO2014066992
    • Husain M, Aameron-Vendrig A, Ni H. Methods for inhibiting platelet aggregation using glp-1 receptor agonists. Google Patents; 2014. WO2014066992.
    • (2014) Google Patents
    • Husain, M.1    Aameron-Vendrig, A.2    Ni, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.